{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:34:33Z","timestamp":1777955673586,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Center for Interdisciplinary Studies and Research","award":["x"],"award-info":[{"award-number":["x"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04875-5","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:17:02Z","timestamp":1774448222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidural cell therapy reduces neurological sequelae severity in canine distemper survivors"],"prefix":"10.1186","volume":"17","author":[{"given":"Jaqueline","family":"Cardoso do Prado Bayma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan Edwin","family":"Baracho Trindade Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Beatriz","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3091-8563","authenticated-orcid":false,"given":"Amanda","family":"Baracho Trindade Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"4875_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-016-0702-z","volume":"12","author":"M Martinez-Gutierrez","year":"2016","unstructured":"Martinez-Gutierrez M, Ruiz-Saenz J. Diversity of susceptible hosts in canine distemper virus infection: A systematic review and data synthesis. BMC Vet Res. 2016;12:1\u201311. https:\/\/doi.org\/10.1186\/s12917-016-0702-z.","journal-title":"BMC Vet Res"},{"issue":"1\u20132","key":"4875_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vetimm.2008.09.023","volume":"127","author":"A Beineke","year":"2009","unstructured":"Beineke A, Puff C, Seehusen F, Baumg\u00e4rtner W. Pathogenesis and immunopathology of systemic and nervous canine distemper. Vet Immunol Immunopathol. 2009;127(1\u20132):1\u201318.","journal-title":"Vet Immunol Immunopathol"},{"key":"4875_CR3","doi-asserted-by":"crossref","unstructured":"Sykes JE, Vandevelde M. Canine distemper virus infection. Greene\u2019s infectious diseases of the dog and Cat. WB Saunders; 2021. pp. 271\u201388.","DOI":"10.1016\/B978-0-323-50934-3.00022-7"},{"key":"4875_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00401-004-0958-4","volume":"109","author":"M Vandevelde","year":"2005","unstructured":"Vandevelde M, Zurbriggen A. Demyelination in canine distemper virus infection: A review. Acta Neuropathol. 2005;109:56\u201368.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"4875_CR5","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.3390\/v6072571","volume":"6","author":"C Lempp","year":"2014","unstructured":"Lempp C, Spitzbarth I, Puff C, Cana A, Kegler K, Techangamsuwan S, Baumg\u00e4rtner W, Seehusen F. New aspects of the pathogenesis of canine distemper leukoencephalitis. Viruses. 2014;6(7):2571\u2013601.","journal-title":"Viruses"},{"issue":"7","key":"4875_CR6","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3390\/ijms20071620","volume":"20","author":"D Klotz","year":"2019","unstructured":"Klotz D, Gerhauser I. Interferon-stimulated genes\u2014mediators of the innate immune response during canine distemper virus infection. Int J Mol Sci. 2019;20(7):1620.","journal-title":"Int J Mol Sci"},{"key":"4875_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-019-1136-6","volume":"16","author":"S Rendon-Marin","year":"2019","unstructured":"Rendon-Marin S, da Fontoura Budaszewski R, Canal CW, Ruiz-Saenz J. Tropism and molecular pathogenesis of canine distemper virus. Virol J. 2019;16:1\u201315.","journal-title":"Virol J"},{"key":"4875_CR8","doi-asserted-by":"crossref","unstructured":"Newbury S. Canine distemper virus. Infectious disease management in animal shelters. Wiley-Blackwell; 2021. pp. 256\u201373.","DOI":"10.1002\/9781119294382.ch11"},{"issue":"4","key":"4875_CR9","first-page":"676","volume":"58","author":"T Devi","year":"2024","unstructured":"Devi T, Asokkumar M, Bharathi MV, Ramesh A, Tirumurugaan KG, Venkataramanan R, Pazhanivel N. Prognostic factorial index for dogs with canine distemper. Indian J Anim Res. 2024;58(4):676\u201380.","journal-title":"Indian J Anim Res"},{"key":"4875_CR10","unstructured":"Fenner FJ, Gibbs EPJ, Murphy FA, Rott R, Studdert MJ, White DO. Veterinary virology. 2nd ed. Academic; 1993."},{"issue":"1","key":"4875_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/jcpa.2001.0521","volume":"126","author":"AF Koutinas","year":"2002","unstructured":"Koutinas AF, Polizopoulou ZS, Baumgaertner W, Lekkas S, Kontos V. Relation of clinical signs to pathological changes in 19 cases of canine distemper encephalomyelitis. J Comp Pathol. 2002;126(1):47\u201356.","journal-title":"J Comp Pathol"},{"key":"4875_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/1087057108321089","volume":"13","author":"JJ Yoon","year":"2008","unstructured":"Yoon JJ, Chawla D, Paal T, Ndungu M, Du Y, Kurtkaya S, et al. High-throughput screening-based identification of paramyxovirus inhibitors. J BioMol Screen. 2008;13:591\u2013608.","journal-title":"J BioMol Screen"},{"key":"4875_CR13","first-page":"283","volume":"78","author":"OV Carvalho","year":"2014","unstructured":"Carvalho OV, Saraiva GL, Ferreira CGT, F\u00e9lix DM, Fietto JLR, Bressan GC, et al. In-vitro antiviral efficacy of ribavirin and interferon-alpha against canine distemper virus. Can J Vet Res. 2014;78:283\u20139.","journal-title":"Can J Vet Res"},{"key":"4875_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2015.00459","volume":"6","author":"R Cox","year":"2015","unstructured":"Cox R, Plemper RK. The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics. Front Microbiol. 2015;6:1\u201312.","journal-title":"Front Microbiol"},{"key":"4875_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-017-0785-6","volume":"14","author":"OV De Carvalho","year":"2017","unstructured":"De Carvalho OV, F\u00e9lix DM, de Camargo Tozato C, Fietto JLR, de Almeida MR, Bressan GC, Pena LJ, Silva-J\u00fanior A. 6-methylmercaptopurine riboside, a thiopurine nucleoside with antiviral activity against canine distemper virus in vitro. Virol J. 2017;14:1\u20138.","journal-title":"Virol J"},{"key":"4875_CR16","doi-asserted-by":"crossref","unstructured":"Pinheiro AO et al. (2016). Controversial results of therapy with mesenchymal stem cells in the acute phase of canine distemper disease. Genet Mol Res, 15(2), e15028211.","DOI":"10.4238\/gmr.15028310"},{"key":"4875_CR17","unstructured":"Sherding RG. (2008). Cinomose canina. In Bichard, S. J., & Sherding, R. G. Manual Saunder: cl\u00ednica de pequenos animais (3rd ed., p. 2048). Roca."},{"issue":"10","key":"4875_CR18","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","volume":"21","author":"S Viswanathan","year":"2019","unstructured":"Viswanathan S, Shi Y, Galipeau J, Krampera M, Leblanc K, Martin I, Nolta J, Phinney DG, Senseb\u00e9 L. Mesenchymal stem versus stromal cells: international society for cell & gene therapy (ISCT\u00ae) mesenchymal stromal cell committee position statement on nomenclature. Cytotherapy. 2019;21(10):1019\u201324.","journal-title":"Cytotherapy"},{"key":"4875_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau J, Sens\u00e9b\u00e9 L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22:824\u201333.","journal-title":"Cell Stem Cell"},{"key":"4875_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s11658-022-00359","volume":"27","author":"M Rahbaran","year":"2022","unstructured":"Rahbaran M, et al. Mesenchymal stem cell-based therapies for neurodegenerative diseases: insights into cell behavior and therapeutic mechanisms. Cell Mol Biology Lett. 2022;27:90. https:\/\/doi.org\/10.1186\/s11658-022-00359-.","journal-title":"Cell Mol Biology Lett"},{"issue":"1","key":"4875_CR21","first-page":"108","volume":"99","author":"I Ubeda-Ba\u00f1on","year":"2021","unstructured":"Ubeda-Ba\u00f1on I, et al. Neuroprotective and anti-inflammatory roles of MSCs in neural trauma. J Neurosci Res. 2021;99(1):108\u201322.","journal-title":"J Neurosci Res"},{"issue":"10","key":"4875_CR22","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jcyt.2019.08.002","volume":"21","author":"S Viswanathan","year":"2019","unstructured":"Viswanathan S, et al. Mesenchymal stem versus stromal cells: ISCT position statement. Cytotherapy. 2019;21(10):1019\u201324.","journal-title":"Cytotherapy"},{"key":"4875_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41582-022-00635-8","volume":"18","author":"J S\u00e1nchez-Ramos","year":"2022","unstructured":"S\u00e1nchez-Ramos J. Mesenchymal stem cells for CNS repair: mechanisms and clinical applications. Nat Reviews Neurol. 2022;18:273\u201386.","journal-title":"Nat Reviews Neurol"},{"issue":"11","key":"4875_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.14295\/bjs.v1i11.191","volume":"1","author":"HDSS Brunel","year":"2022","unstructured":"Brunel HDSS, Villaroel CL, Dallago BSL, Pogue R, Malard PF. Retrospective study of mesenchymal stem cell therapy in dogs with neurological complications resulting from infection by canine distemper virus. Brazilian J Sci. 2022;1(11):73\u201381.","journal-title":"Brazilian J Sci"},{"issue":"1","key":"4875_CR25","first-page":"202","volume":"34","author":"ABH Trindade","year":"2021","unstructured":"Trindade ABH, Trindade JEBH. Mesenchymal stem cell injection achieves closure of chronic wound in canine patient: A case report. Biomedical J Sci Technol Res. 2021;34(1):202.","journal-title":"Biomedical J Sci Technol Res"},{"issue":"1","key":"4875_CR26","first-page":"31","volume":"64","author":"RV Novaes","year":"2023","unstructured":"Novaes RV, Hill JEBT, Hill ABT. Efficacious cellular therapy of Descemetocele in a dog. Can Veterinary J. 2023;64(1):31\u20133.","journal-title":"Can Veterinary J"},{"issue":"3","key":"4875_CR27","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/jvim.16717","volume":"37","author":"R Gon\u00e7alves","year":"2023","unstructured":"Gon\u00e7alves R, Maddox TW, Phillipps S, Nagendran A, Cooper C, Orlandi R, Fentem R, Walmsley GL. Development of a reliable clinical assessment tool for meningoencephalitis in dogs: the neurodisability scale. J Vet Intern Med. 2023;37(3):1111\u20138.","journal-title":"J Vet Intern Med"},{"issue":"9","key":"4875_CR28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2460\/javma.252.9.1073","volume":"252","author":"MA Giuffrida","year":"2018","unstructured":"Giuffrida MA, Brown DC, Ellenberg SS, Farrar JT. Development and psychometric testing of the canine Owner-Reported quality of life questionnaire, an instrument designed to measure quality of life in dogs with cancer. J Am Vet Med Assoc. 2018;252(9):1073\u201383.","journal-title":"J Am Vet Med Assoc"},{"issue":"2","key":"4875_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/wics.199","volume":"4","author":"AA Neath","year":"2012","unstructured":"Neath AA, Cavanaugh JE. The bayesian information criterion: Background, derivation, and applications. Wiley Interdisciplinary Reviews: Comput Stat. 2012;4(2):199\u2013203.","journal-title":"Wiley Interdisciplinary Reviews: Comput Stat"},{"key":"4875_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fvets.2020.00080","volume":"7","author":"BD Story","year":"2020","unstructured":"Story BD, Miller ME, Bradbury AM, Million ED, Duan D, Taghian T, Faissler D, Fernau D, Beecy SJ, Gray-Edwards HL. Canine models of inherited musculoskeletal and neurodegenerative diseases. Front Veterinary Sci. 2020;7:80.","journal-title":"Front Veterinary Sci"},{"key":"4875_CR31","volume-title":"Tratamento com c\u00e9lulas-tronco mesenquimais Em c\u00e3es Apresentando sequela neurol\u00f3gica decorrente Da cinomose: Relato de Caso","author":"AL Santos","year":"2015","unstructured":"Santos AL, et al. Tratamento com c\u00e9lulas-tronco mesenquimais Em c\u00e3es Apresentando sequela neurol\u00f3gica decorrente Da cinomose: Relato de Caso. BA: BIOCELL. Porto Seguro; 2015."},{"key":"4875_CR32","unstructured":"Marques ARPA. (2016). Terapia com c\u00e9lulas estaminais derivadas do tecido adiposo em c\u00e3es com sequelas neurol\u00f3gicas da esgana (Disserta\u00e7\u00e3o de mestrado)."},{"key":"4875_CR33","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves DSV, Gomes MVS, Guterra VLP, Lucchi-Rodrigues AF, Mathias CHT, Maestri LFP, Arg\u00f4lo-Neto NM, Monteiro BS. (2018). Mesenchymal stem cell infusion for the treatment of neurological sequelae of canine distemper virus: A clinical study. Genet Mol Res, 17.","DOI":"10.4238\/gmr18088"},{"key":"4875_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/scrt312","volume":"4","author":"N De Vocht","year":"2013","unstructured":"De Vocht N, Praet J, Reekmans K, Le Blon D, Hoornaert C, Daans J, Berneman Z, Van der Linden A, Ponsaerts P. Tackling the physiological barriers for successful mesenchymal stem cell transplantation into the central nervous system. Stem Cell Res Ther. 2013;4:1\u201312.","journal-title":"Stem Cell Res Ther"},{"issue":"13","key":"4875_CR35","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.3390\/jcm10132925","volume":"10","author":"M Sanchez-Diaz","year":"2021","unstructured":"Sanchez-Diaz M, et al. Biodistribution of mesenchymal stromal cells after administration in animal models and humans: A systematic review. J Clin Med. 2021;10(13):2925. https:\/\/doi.org\/10.3390\/jcm10132925.","journal-title":"J Clin Med"},{"key":"4875_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-021-00694-2","volume":"11","author":"G Bahlakeh","year":"2021","unstructured":"Bahlakeh G, Rahbarghazi R, Mohammadnejad D, Abedelahi A, Karimipour M. Current knowledge and challenges associated with targeted delivery of neurotrophic factors into the central nervous system: focus on available approaches. Cell Bioscience. 2021;11:1\u201324.","journal-title":"Cell Bioscience"},{"issue":"11","key":"4875_CR37","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.3390\/ijms20112624","volume":"20","author":"RA Shahror","year":"2019","unstructured":"Shahror RA, et al. Enhanced homing of mesenchymal stem cells overexpressing fibroblast growth factor 21 to injury site in a mouse model of traumatic brain injury. Int J Mol Sci. 2019;20(11):2624. https:\/\/doi.org\/10.3390\/ijms20112624.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4875_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/jnr.23341","volume":"92","author":"S Gavrilovic","year":"2014","unstructured":"Gavrilovic S, et al. In vivo tracking of neuronal-like cells by magnetic resonance in a rabbit model of spinal cord injury. J Neurosci Res. 2014;92(2):265\u201376. https:\/\/doi.org\/10.1002\/jnr.23341.","journal-title":"J Neurosci Res"},{"key":"4875_CR39","unstructured":"Ramos MC. (2020). Homing of canine multipotent mesenchymal stromal cells after epidural transplant in a rabbit model of compressive spinal cord injury."},{"key":"4875_CR40","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1038\/s41598-017-02137-w","volume":"7","author":"I Lee","year":"2017","unstructured":"Lee I, Huang S, Chuang C, et al. Delayed epidural transplantation of human induced pluripotent stem cell-derived neural progenitors enhances functional recovery after stroke. Sci Rep. 2017;7:1943.","journal-title":"Sci Rep"},{"issue":"2","key":"4875_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/jvim.16745","volume":"38","author":"D Ito","year":"2024","unstructured":"Ito D, Lukacs Z, Levy K, Hamilton S, Worth A, Lascelles BDX. Development and psychometric validation of a feline health-related quality of life questionnaire (HRQL). J Vet Intern Med. 2024;38(2):519\u201329. https:\/\/doi.org\/10.1111\/jvim.16745.","journal-title":"J Vet Intern Med"},{"issue":"5","key":"4875_CR42","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/ani13050852","volume":"13","author":"AL Hampton","year":"2023","unstructured":"Hampton AL, Wirth W, Trachsel M, et al. Development of a canine quality of life assessment tool for clinical trials in veterinary medicine. Animals. 2023;13(5):852. https:\/\/doi.org\/10.3390\/ani13050852.","journal-title":"Animals"},{"key":"4875_CR43","first-page":"132","volume":"18","author":"R P\u00e9rez-Gonz\u00e1lez","year":"2021","unstructured":"P\u00e9rez-Gonz\u00e1lez R, et al. Neurological sequelae and cell therapy outcomes: A systematic review. Neurotherapeutics. 2021;18:132\u201345.","journal-title":"Neurotherapeutics"},{"issue":"2","key":"4875_CR44","first-page":"77","volume":"8","author":"AGR Lima","year":"2023","unstructured":"Lima AGR, et al. Resistance of myoclonus to mesenchymal stem cell therapy in dogs. Veterinary Neurol J. 2023;8(2):77\u201384.","journal-title":"Veterinary Neurol J"},{"issue":"6","key":"4875_CR45","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00005-012-0194-x","volume":"60","author":"A Bajek","year":"2012","unstructured":"Bajek A, et al. Adipose-derived stem cells as a tool in cell-based therapies. Arch Immunol Ther Exp. 2012;60(6):437\u201349. https:\/\/doi.org\/10.1007\/s00005-012-0194-x.","journal-title":"Arch Immunol Ther Exp"},{"issue":"12","key":"4875_CR46","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/jor.22437","volume":"31","author":"M Bethel","year":"2013","unstructured":"Bethel M, et al. Age-related changes in bone-marrow mesenchymal stem cells: reduced osteogenic potential and increased adipogenic potential. J Orthop Res. 2013;31(12):1913\u20138. https:\/\/doi.org\/10.1002\/jor.22437.","journal-title":"J Orthop Res"},{"key":"4875_CR47","doi-asserted-by":"publisher","unstructured":"Li H et al. (2014). Aging and stress-induced oxidative stress in human bone marrow-derived mesenchymal stem cells: Implications for cell-based therapy. Oxidative Medicine and Cellular Longevity, 2014, 1\u201312. https:\/\/doi.org\/10.1155\/2014\/216210","DOI":"10.1155\/2014\/216210"},{"issue":"9","key":"4875_CR48","doi-asserted-by":"publisher","first-page":"739","DOI":"10.5966\/sctm.2012-0138","volume":"2","author":"A S\u00e9mont","year":"2013","unstructured":"S\u00e9mont A, et al. Mesenchymal stem cells improve colonic healing through regulation of endogenous epithelial cell proliferation and apoptosis. Stem Cells Translational Med. 2013;2(9):739\u201349. https:\/\/doi.org\/10.5966\/sctm.2012-0138.","journal-title":"Stem Cells Translational Med"},{"issue":"2","key":"4875_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s12276-023-00940-2","volume":"55","author":"DV Pham","year":"2023","unstructured":"Pham DV, Nguyen TK, Park PH. Adipokines at the crossroads of obesity and mesenchymal stem cell therapy. Exp Mol Med. 2023;55(2):313\u201324.","journal-title":"Exp Mol Med"},{"issue":"1","key":"4875_CR50","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41392-024-01936-8","volume":"9","author":"Y Shan","year":"2024","unstructured":"Shan Y, Zhang M, Tao E, Wang J, Wei N, Lu Y, Liu Q, Hao K, Zhou F, Wang G. Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges. Signal Transduct Target Therapy. 2024;9(1):242.","journal-title":"Signal Transduct Target Therapy"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04875-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04875-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04875-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:52:36Z","timestamp":1777935156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-025-04875-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4875"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04875-5","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was approved by the Ethics Committee of the Centro Universit\u00e1rio Max-Planck (UniMAX), Indaiatuba, SP, Brazil, under Certificate number PAX002-2020 \u201cCell therapy in veterinary medicine: analysis of common cases in clinical routine\u201d, approved in 02\/03\/2022. This experiment was conducted in accordance with the ethical standards of the Brazilian National Council for the Control of Animal Experimentation. All owners of the participating dogs provided written informed consent for participation in the study. The canine cells used in this study were donated from CellTech, and followed the same Ethics Committee approval number. No human cells were used in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"ABTH and JEBTH are affiliated with CellTech- Tecnologias com c\u00e9lulas tronco research center, which was involved in processing the cells used in this study. However, they did not participate in the stromal cell clinical application and clinical evaluation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}